Lixte Biotechnology Holdings's total assets for Q4 2025 were $12.73M, an increase of 134.35% from the previous quarter. LIXT total liabilities were $1.77M for the fiscal quarter, a 239.85% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.